Calumet, INC /DE Form 4 insider transactions
NASDAQ
CLMT
Calumet, INC /DECalumet Director Raymond Paul C acquired 3,796 shares of common stock through the conversion of vested Restricted Stock Units.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director Daniel J. Sajkowski vested 3,796 Restricted Stock Units, with 40% settled in cash and the remainder added to his direct ownership.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director John G. Boss reported the vesting of Restricted Stock Units and a subsequent adjustment to his common stock holdings.
NASDAQ
CLMT
Calumet, INC /DECalumet Director Stephen P. Mawer reported the acquisition and subsequent partial disposition of common stock related to vested Restricted Stock Units.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director Raymond Paul C received grants of Restricted Stock Units, totaling 2,148 units, as reported in a recent SEC Form 4 filing.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director John G. Boss acquired a total of 644 Restricted Stock Units, including 483 fully vested units and 161 units under a deferred compensation plan.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. director Stephen P. Mawer was granted 2,954 Restricted Stock Units as part of his compensation.
NASDAQ
CLMT
Calumet, INC /DECalumet Director Amy Schumacher received a grant of 1,965 Restricted Stock Units on August 5, 2025.
NASDAQ
CLMT
Calumet, INC /DEGregory J. Morical, SVP and General Counsel of Calumet, Inc., reported the sale of 25,123 shares of common stock on June 16, 2025, for a weighted average price of $16.69 per share, pursuant to a Rule 10b5-1 plan.
NASDAQ
CLMT
Calumet, INC /DEDirector Jennifer Straumins sold 150,000 shares of Calumet Inc. common stock in two transactions on June 13 and June 16, 2025.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director Karen A. Twitchell was granted 7,067 Restricted Stock Units, which are set to vest by June 2026, as disclosed in a recent SEC Form 4 filing.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director John G. Boss was granted 7,067 Restricted Stock Units on June 11, 2025, aligning his interests with shareholders.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director Raymond Paul C was granted 7,067 Restricted Stock Units, which are set to vest by June 2026.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director Jennifer Straumins was granted 7,067 Restricted Stock Units, which are scheduled to vest by June 2026.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director Stephen P. Mawer has been granted 13,780 Restricted Stock Units (RSUs) as part of his compensation, aligning his interests with shareholders.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director Daniel J. Sajkowski was granted 7,067 Restricted Stock Units on June 11, 2025, as reported in a recent SEC Form 4 filing.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director Amy Schumacher was granted 7,067 Restricted Stock Units as part of her compensation, which are set to vest by June 2026.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director Julio M. Quintana was granted 7,067 Restricted Stock Units (RSUs) on June 11, 2025, aligning his interests with shareholders.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. director Karen G. Narwold was granted 7,067 Restricted Stock Units (RSUs) on June 11, 2025, as part of her compensation.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director Daniel L. Sheets reported the acquisition and immediate vesting of 3,796 Restricted Stock Units, as detailed in a recent SEC Form 4 filing.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director James S. Carter reported the acquisition of 3,796 fully vested Restricted Stock Units, as disclosed in a recent SEC Form 4 filing.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director Karen A. Twitchell reported the acquisition of 3,796 fully vested Restricted Stock Units on June 9, 2025, as disclosed in a recent SEC Form 4 filing.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director Amy M. Schumacher was granted 3,796 fully vested Restricted Stock Units, aligning her interests with shareholders.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director Paul C. Raymond was granted 3,796 restricted stock units (RSUs) on June 9, 2025, as disclosed in a recent SEC Form 4 filing.
NASDAQ
CLMT
Calumet, INC /DEForm 4: Calumet Director Jennifer Straumins Reports Grant of 3,796 Fully Vested Restricted Stock Units
Calumet, Inc. Director Jennifer Straumins has reported the acquisition of 3,796 fully vested Restricted Stock Units, effective June 9, 2025, as disclosed in a recent SEC Form 4 filing.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director Daniel J. Sajkowski was granted 3,796 restricted stock units, which are 100% vested and will be settled upon vesting, as reported in a recent SEC Form 4 filing.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director John G. Boss has acquired 3,796 fully vested Restricted Stock Units, as reported in a recent SEC Form 4 filing.
NASDAQ
CLMT
Calumet, INC /DECalumet, Inc. Director Stephen P. Mawer was granted 7,403 fully vested Restricted Stock Units, as disclosed in a recent SEC Form 4 filing.
NASDAQ
CLMT
Calumet, INC /DEJennifer Straumins, a Director at Calumet, Inc., sold 100,000 shares of common stock for $13.17 per share on June 5, 2025, as part of a Rule 10b5-1 trading plan.
NASDAQ
CLMT
Calumet, INC /DEJames S. Carter, a Director at Calumet, Inc., has acquired a substantial number of call options, signaling increased insider confidence in the company's future performance.